HEAL Initiative: Justice Community Overdose Innovation Network (JCOIN) - Phase II Methodology and Advanced Analytics Resource Center (UM1 Clinical Trial Not Allowed)
Funding Opportunity RFA-DA-24-068 from the NIH Guide for Grants and Contracts. The intersection of justice and community-based health systems is a critical target for addressing the opioid crisis. The National Institute on Drug Abuse intends to establish the Justice Community Overdose Innovation Network (JCOIN) using the cooperative agreement mechanism. The purpose of the network is to establish a national consortium of investigators examining promising interventions and other approaches that can improve the capacity of the justice system to effectively respond to the opioid epidemic. The structure of the network shall...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 21, 2023 Category: Research Source Type: funding
Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed)
Funding Opportunity PAR-23-240 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIAAA/NIDA R25 program is to support educational activities that foster a better understanding of biomedical, behavioral, and clinical research on alcohol and other substance use disorders and their implications. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Outreach. Specifically, this FOA will support projects designed to engage...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 1, 2023 Category: Research Source Type: funding
Addressing HIV in highest risk sexual and gender minorities (R34 Clinical Trial Required)
Funding Opportunity RFA-DA-25-002 from the NIH Guide for Grants and Contracts. Substance use needs to be better incorporated into interventions for the engagement and retention of sexual minority persons in prevention and care with attention to emergent interventions such as long-acting PrEP. Social determinants of health associated with HIV and problematic substance use such as homelessness and criminal justice involvement also demonstrate disproportionate impact among sexual and gender minorities and need attention. Changing self-definition of sexual minority status has implications for outreach and provider stigma an...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 31, 2023 Category: Research Source Type: funding
Addressing HIV in Highest Risk Sexual and Gender Minorities (R01 Clinical Trial Optional)
Funding Opportunity RFA-DA-25-001 from the NIH Guide for Grants and Contracts. Substance use needs to be better incorporated into interventions for the engagement and retention of sexual minority persons in prevention and care with attention to emergent interventions such as long-acting PrEP. Social determinants of health associated with HIV and problematic substance use such as homelessness and criminal justice involvement also demonstrate disproportionate impact among sexual and gender minorities and need attention. Changing self-definition of sexual minority status has implications for outreach and provider stigma an...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 31, 2023 Category: Research Source Type: funding
Empowering Rural Communities in California to End the Tobacco Epidemic
Funding to implement policy, systems, and environmental change strategies by engaging rural residents in California to address tobacco disparities. Geographic coverage: California -- California Department of Public Health (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - July 26, 2023 Category: American Health Source Type: funding
The Role of Sleep Deficiency in Persons with Type 1 Diabetes: Sleep, Glycemic Control, and Cardiovascular Risk (R01 Clinical Trial Optional)
Funding Opportunity RFA-HL-24-008 from the NIH Guide for Grants and Contracts. The purpose of this NOFO is to elucidate the contribution of sleep deficiency and circadian disruption to metabolic and cardiovascular pathobiology, disease trajectory, and treatment response in individuals living with Type 1 Diabetes (T1D). The RFA will support clinically relevant, mechanism focused research on the interface between sleep, circadian rhythms biology, T1D and cardiovascular disease. Multi-disciplinary teams bridging sleep/circadian, diabetes, and cardiovascular research are encouraged. Proposed research should be relevant to t...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 20, 2023 Category: Research Source Type: funding
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial optional)
Funding Opportunity RFA-DA-25-020 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support the testing of enhanced models of care that optimally integrate HIV, addiction, and primary care services. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 19, 2023 Category: Research Source Type: funding
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial required)
Funding Opportunity RFA-DA-25-019 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support the testing of enhanced models of care that optimally integrate HIV, addiction, and primary care services. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 19, 2023 Category: Research Source Type: funding
Development of Software for Data Science in Infectious and Immune-Mediated Diseases Research (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-23-038 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for the development of software to improve the acquisition, management, analysis, visualization, and dissemination of data and knowledge for data science research on infectious and immune-mediated diseases (IID). Relevant IID data science research comprises, but is not limited to, computational methods to better understand disease mechanism, risk prediction, epidemiology, detection and diagnosis, treatment, and vaccines, aligned with the research mission of NI...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 12, 2023 Category: Research Source Type: funding
Quantifying the Impact of Environmental Toxicants on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Risk in Cohort Studies (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-24-022 from the NIH Guide for Grants and Contracts. This funding opportunity announcement will support research focused on major toxicants observed to be associated with elevated AD risk, and health disparities in AD-related pathologic and clinical outcomes. This funding opportunity aims to enrich existing longitudinal cohorts with measures of exposures to individual toxicants or combinations of toxicants and/or multi-omics molecular profiling that reflects the bodys response to exposure(s), support the development of multi-disciplinary teams needed for the rigorous measurement and assessment ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 15, 2023 Category: Research Source Type: funding
HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices (RM1 Clinical Trial Optional)
Funding Opportunity RFA-NS-23-028 from the NIH Guide for Grants and Contracts. More than 25 million Americans suffer from daily chronic pain, a highly debilitating medical condition that is complex and difficult to manage. In recent decades, there has been an overreliance in the prescription of opioids for chronic pain despite their poor ability to improve function and high addiction liability. This contributed to a significant and alarming epidemic of opioid overdose deaths and addictions. Innovative scientific solutions to develop alternative pain treatment options are thus critically needed. Through targeted research...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 27, 2023 Category: Research Source Type: funding
Ending the HIV Epidemic: Resource Center to Engage Justice-Involved Populations (U24 Clinical Trial Optional)
Funding Opportunity RFA-DA-24-022 from the NIH Guide for Grants and Contracts. The goal of this initiative is to develop a patient-focused research resource center to support the work of the HIV/Justice Regional Research Hubs described in RFA-DA-24-105. The project will create a Patient Engagement Resource Center (PERC) that will partner with patients and others having lived experience with HIV, SUD, and the criminal legal system to form a research advisory/consultation model that can support the Regional Research Hub projects. In addition, the awardee will conduct original research to identify key access and utilizatio...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 19, 2023 Category: Research Source Type: funding
Ending the HIV Epidemic: Focus on Justice Populations with SUD-Data Coordination and Dissemination Center (UM1 Clinical Trial Optional)
Funding Opportunity RFA-DA-24-023 from the NIH Guide for Grants and Contracts. This goal of this initiative is to focus on HIV prevention and treatment implementation research in justice populations with substance use disorders. The proposed initiative would focus on creating national research capacity targeted to geographic regions where there are spikes in HIV cases. Through this initiative, studies would be conducted that systematically identify individuals at most risk for acquiring or transmitting HIV as they come into contact with the justice system and connecting this population with relevant HIV and substance us...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 19, 2023 Category: Research Source Type: funding
Ending the HIV Epidemic: Focus on Justice Populations with SUD (R61/R33 Clinical Trial Required)
Funding Opportunity RFA-DA-24-015 from the NIH Guide for Grants and Contracts. Under the Ending the HIV Epidemic (EHE) initiative, the National Institute on Drug Abuse (NIDA) is releasing a set of interrelated RFAs to create the HIV/Justice Research Network, a coordinated effort to study innovative strategies to promote improvements in HIV prevention and treatment services for individuals involved in the criminal legal system with substance use disorder (SUD). Separate FOAs are being issued to support three components: multiple Regional Research Hubs (RRH; RFA-DA-24-015); one Data Coordination and Dissemination Center (...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 19, 2023 Category: Research Source Type: funding
Pulmonary Outcomes and Sequelae after Treatment-TB (POST-TB) (R01 Clinical Trial Optional)
Funding Opportunity PAR-23-148 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support applications for epidemiological and observational research projects on the long-term cardiopulmonary sequelae following treatment for tuberculosis (TB). Investigators should propose additional testing and data collection in existing cohorts of adult and/or pediatric TB participants to better characterize and understand adverse outcomes and morbidity associated with TB disease post treatment in individuals with and without HIV infection. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 30, 2023 Category: Research Source Type: funding
